The global Pneumococcal Vaccination market size is predicted to grow from US$ 10310 million in 2025 to US$ 19320 million in 2031; it is expected to grow at a CAGR of 11.0% from 2025 to 2031.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.

Infinity Market Research newest research report, the Pneumococcal Vaccination Industry Forecast looks at past sales and reviews total world Pneumococcal Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Pneumococcal Vaccination sales for 2025 through 2031. With Pneumococcal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Vaccination industry.

This Insight Report provides a comprehensive analysis of the global Pneumococcal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pneumococcal Vaccination market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Vaccination.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccination market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    PPSV 23
    PCV 13
    PCV 10

Segmentation by Application:

    Child
    Adult

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Pfizer
    GSK
    MSD
    CDIBP
    WALVAX
    Sinovac
    Bio Kangtai

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pneumococcal Vaccination market?
What factors are driving Pneumococcal Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Vaccination market opportunities vary by end market size?
How does Pneumococcal Vaccination break out by Type, by Application?